Plerixafor use in New Zealand 2016-2019: An Observational Study.
Sign Up to like & getrecommendations! Published in 2022 at "Internal medicine journal"
DOI: 10.1111/imj.15819
Abstract: INTRODUCTION Plerixafor is used to mobilise CD34-positive stem cells for autologous transplantation to treat haematological malignancy. Funded in New Zealand since 2016, plerixafor can be used "pre-emptively" to salvage a failing first attempt or as… read more here.
Keywords: zealand; new zealand; plerixafor use; use new ... See more keywords